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Abstract The kinetics of complexing inactivation at identical 
enzyme and inhibitor concentrations were analyzed and the 
equations of product generation were derived when the free 
enzyme concentration is great, larger or smaller than the 
dissociation constant of inhibitor, A'|. The kinetic constants can 
be obtained by fitting the derived equations to the progress curve. 
Numerical examples show that this method is valid and gives 
satisfactory results. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Recent developments showed that irreversible modification 
of enzyme activity is as important as, if not more important 
than, reversible inhibition. Affinity labeling has been used ex-
tensively for the study of the active sites of enzymes [1-4]. 
Modifiers that complex specifically to the active sites of en-
zymes prior to the irreversible modification step appear to 
have great prospects as therapeutic agents [4,5]. Many highly 
selective irreversible inhibitors of proteinases developed re-
cently [6] belong to this kind of inhibitors. Most of them 
possess a very high affinity for enzyme, i.e. so-called tight-
binding, complexing irreversible inhibitors with a K\ value 
being as low as 1CT9 M [7,8]. The tight-binding, complexing 
inactivation is often studied by the traditional method taking 
aliquots for residue activity assay [9]. This method is not only 
laborious, but also not suitable for fast reaction and cannot 
avoid the dilution effect on the assay. Although a convenient 
approach [10,11] has been extensively used to study the en-
zyme inactivation, it is not applicable to the inactivation at 
identical enzyme and inhibitor concentrations. Recently, a 
simple method was adopted to study the modulation of pro-
teinase inhibitors [12-14], but with the disadvantage that the 
necessary condition of [E] <K K\ was not considered, so that it 
was mistakenly applied to the case of [E] > Ki [12,13]. 
In the present paper, a simple method for the study of the 
tight-binding, complexing irreversible inhibitors is presented. 
The relations between the amount of product formation and 
time at identical enzyme and inhibitor concentrations were 
derived under the conditions of [ E ] » A T and [E]«;Aj, respec-
tively. The kinetic constants can be determined by fitting the 
derived equations to the progress curve. 
2. Theory 
2.1. Kinetic analysis 
An inhibitor (7) inhibits an enzyme (E) in a two-step reac-
tion, first forming a reversible complex, El, followed by slow 
transformation to a functionally irreversible complex, El*. 
The inactivation in the presence of substrate (S) is modeled 
by Scheme 1, where K\ is the dissociation constant of inhibitor 
from El, ky is the inactivation rate constant, ES is the enzyme-
substrate complex and Km, is the Michaelis-Menten constant. 
The following assumptions are adopted: 
1. Steady states between E+S and ES, E+I and El are 
rapidly reached, and the irreversible conversion of El 
to El* is a slow step, i.e., the rate-limiting step of the 
inactivation. 
2. The substrate concentration is sufficiently high that the 
depletion of free substrate by binding to the enzyme and 
that by conversion into product are both negligible. 
3. There is no product inhibition. 
For inhibitors with ^i'— 10 9 M or less, the experiments 
must be performed under the condition of comparable enzyme 
and inhibitor concentrations. 
According to the assumptions above and Scheme 1, we 
have: 
Mo = PI + [EI] + PI*] (1) 
Km k2 
S + E , * ES ► E + P 
K, 
El 
h 
El* 
*Corresponding author. Fax: (86) 10-62022026. Scheme 1. 
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[E]0 = [E]T + [EF] 
[E]T = [E] + [ES] + [El] 
(2) 
(3) 
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ing equation [15]: 
* " / [Ei„-rao-sM±^+ 
2(Km + Kjr, 
[E][S] 
[ES] 
[E][I] 
[El] 
— -ft-m 
= Kj 
From Eqs. 
[EI] = IV 
1, 2 and 5, 
-[E]0 + [E]T 
1 + ^ 
[E] 
we have 
(4) 
(5) 
(6) 
Substituting Eqs. 4 and 6 into Eq. 3 yields: 
[E]T - |E| + [ES] + [El] _ 
1 + H)lg+(1+MWffldS.H (T, 
The velocity of irreversible decrease of [E]T at any time is 
given by: 
d[E]T 
dt 
-A:; [El] 
By substituting Eqs. 6 and 7 into Eq. 8, we have: 
d[E] ^ [E]{(l+£)[E] + [I]0-[E]o} 
d ' V i + | ^ ) ( 2 [ E ] + J s : I ) + [i]0-[E]0 
(8) 
(9) 
When [E]o equals to [I]0, Eq. 9 can be simplified as follows: 
d [ E ] = _ f c ; _ [E]
2 
dt ' 2[E] + Ki 
From Eq. 4, we have: 
Therefore, Eq. 10 can be expressed as: 
dv v2 
■ffm 
(10) 
(11) 
(12) 
By integrating Eq. 12 with the boundary conditions of t-0, 
v = vj, we obtain: 
21nvs + WS]/i_n=^ 
v Km \v vy 
(13) 
where v and vj a r e the velocities at any given time and time 
zero in the presence of inhibitors, respectively. 
The relation between Vg and [E]0, [I]o is given by the follow-
[E]0 + [I]o+*i Km 
-4[E]0[I]0 
When [E]o = [I]o, this can be simplified as follows: 
v0 \
 + *J2[E]01
 + V KjKm + [S] 
+ V + *I*m+[S] 
By solving Eq. 14, 
y J^MA 
M (Km + [S])(v0-
where 
r _^[S][E] 0 
we obtain: 
-K) 
(14) 
(15) 
" Km + [S] 
Integrating Eq. 13 by parts with the boundary conditions of 
t = 0, [P] = 0 and v = vj gives: 
[P] = f'v 
Jo 
dt: :
2(vg-v) | KMS\ [nv*0 
ki Kmk; v 
(16) 
2.2. Approximation 
From Eq. 14, we have: 
lET _U_, , I, , JE]0 Km 
K, 2\ 1 + V 1 + 4 J K ' I ^ m + [S] 
(17) 
where [E]* is the free enzyme concentration at time zero. 
From Eq. 17, it can be seen that the condition of [E]3>ATi 
at time zero can be easily satisfied when: 
| E l o » i M X l 
Thus, Eq. 10 can be simplified as: 
d [E]_ k 
^T""2 [E ] 
From Eqs. 11 and 18, we have: 
dv ki 
d7 = ~Iv 
and hence 
(18) 
(19) 
By integrating Eq. 19 with the boundary conditions of f = 0, 
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[P] = 0, we can obtain the equation for product formation with 
time: 
[P]=fkl-e"^2) (20) 
It should be pointed out that [E] will decrease with time 
during inactivation, the condition of [E]a>Aj can only be 
satisfied during the initial par t of the progress curve, and 
thus only the initial par t of the progress curve can be de-
scribed by Eq. 20. 
According to Eq. 17, when: 
[E]0 
2(Km + [S]) 
K, 
we have [ E ] < K A J , thus Eq. 10 can be simplified as : 
d[E] 
d; 
F rom Eqs. 11 and 21, we have: 
1 1 Kmk 
- = 1 t 
v v^ k2Ki[S] 
and hence 
(21) 
(22) 
(23) 
Clearly, Eqs. 21-23 are valid for the whole progress curve 
because [E] decreases with time and the condition of [E] <K K\ 
is always satisfied. 
200 400 600 
time (s) 
Fig. 1. A simulated progress curve of product formation for the 
tight-binding, complexing inactivation when [E]s>Jq. The progress 
curve, (o), represents the values calculated according to Eqs. 13 and 
16 with [S] = 2000 uM, [E]0 = [I]0 = 50 nM, ii:m = 400 uJVI, k2 = W 
s_1, A"i = 0.5 nM, k[ = 0.025 s_1, and a Gaussian-type error of up to 
2.5% of the product formed using a random number generator. The 
smooth curve is the fitted result using a non-linear fitting program. 
The inset shows the enlarged initial part. 
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Fig. 2. A simulated progress curve of product formation for the 
tight-binding, complexing inactivation when [E]<KA"I. The progress 
curve, (0)> represents the values calculated according to Eqs. 13 and 
16 with [S] = 4000 |xM, [E]0 = [I]0=0.05 nM, Km = 400 itM, fc2 = 5000 
s_1, Ki = 0.5 nM, ki = 2.5 s_1, and a Gaussian-type error of up to 
2.5% of the product formed using a random number generator. The 
smooth curve is the fitted result using a non-linear fitting program. 
The inset shows the enlarged initial part. 
2.3. Determination of the kinetic constants 
The kinetic constants can be determined by the following 
procedures: 
1. Determination of vo, vj$, Km and ki from the experi-
ments, where vjj can be determined from the tangent 
line at time zero of the progress curve in the presence 
of inhibitor. 
Calculation for K\ according to Eq. 15. 
Determining the irreversible inactivation rate constant k\ 
according to Eq. 20 under the condition of: 
or to Eq. 23 under the condition of: 
An, 
Table 1 
Parameters determined by the present method under different condi-
tions 
Parameters determined 
h (s-1) KT (nM) k-JKi (nM^
1 s"1) 
(I) 
(II) 
0.025 ±0.006 
2.518 ±0.005 
2.785 ±0.078* 
0.508 ±0.005 
0.506 ±0.003 
0.049 
4.976 
(I) The conditions are the same as in Fig. 1. 
(II) The conditions are the same as in Fig. 2, *determined by plotting 
method [12-14]. 
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3. Numerical examples 
The present method was applied to the simulation of the 
tight-binding, complexing inactivation by a numerical exam-
ple under the condition of [ E ] : ^ ^ , i.e., 
as shown in Fig. 1. The progress curve was generated with 
computer according to Eqs. 13 and 16, and then, Eq. 20 was 
fitted to the initial part using a non-linear fitting program. 
The inset shows the enlarge part of the initial part of the 
progress curve with being fitted well. The kinetic constants 
obtained were listed in Table 1. 
A simulated progress curve of the tight-binding complexing 
inactivation under the condition of [E]«:.Ki, i.e., 
was obtained according to Eqs. 13 and 16 as given in Fig. 2. 
Eq. 23 was well fitted to the whole progress curve. It can be 
seen that the kinetic constants obtained by the present ap-
proach as shown in Table 1 are consistent with the given 
values (in the legend of Figs. 1 and 2) which are used to 
generate the progress curves. For comparison, the value of 
k\ determined from the plot of 1/v against t [12-14] is shown 
in Table 1. 
4. Discussion 
During the last decade, a systematic study on the kinetics of 
irreversible modification of enzyme activity has been pre-
sented [11]. However, for a tight-binding complexing type in-
hibitor, the experiment must be performed at comparable or 
identical enzyme and inhibitor concentrations. Thus the con-
centration of inhibitor can not be considered as a constant 
during the modification. In this case, no explicit equation in 
terms of time can be obtained [15-18]. A numerical method 
[15] and several graphic methods [16-18] have been proposed 
to determine the kinetic constants for the slow, tight-binding 
reversible inhibition. However, the numerical method [15] 
needs a special computing program; the graphic methods 
[16-18] rely on the accurate estimation of the initial and 
steady-state rates and thus large error would probably arise 
from experiment. 
In the present paper, a method was proposed to determine 
the kinetic constants for tight-binding, complexing inactiva-
tion. According to the equations derived under the condition 
of: 
or 
the kinetic constants can be obtained from fitting the derived 
equations to the progress curve using a non-linear fitting pro-
gram. This is a simple, accurate method because the kinetic 
constants can be accurately determined from one experiment 
as shown in the numerical examples. 
Recently, a simple method was proposed [12-14], in which 
the two-step inactivation was treated as one step and then the 
kinetic constants were determined from the linear plot of 1/v 
against t, but with disadvantage that large error would prob-
ably arise from the velocity obtained by the tangent line of the 
progress curve of product formation. This has been proved by 
comparing the value of fa obtained by the plotting method to 
that by the present method as shown in Table 1. Besides, the 
necessary condition of [E] <K K\ for being treated as one step 
was not considered, so that it was mistakenly applied to the 
case of [E]>Aj [12,13]. The problem mentioned above will 
not occur if the method presented in this paper is adopted. 
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